Impact GLP-1 Agonists Following Bariatric
Impact GLP-1 Agonists Following Bariatric
Recruiting · NCT06132477 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact GLP-1 Agonists Following Bariatric | Apnea, Body Weight, Dyssomnias, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, hypertensive disorder, metabolic disease, morbid obesity, nervous system disorder, nutritional disorder, obesity disorder, obstructive sleep apnea syndrome, overnutrition, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, vascular disorder | Recruiting | Phase 4 | 2026-09-10 | NCT06132477 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| American Society for Metabolic and Bariatric Surgery | 2 |
| University of Missouri-Columbia | 91 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Missouri Hospital | Columbia | United States | 1 |